Arrowstreet Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-6,700
| Closed | -$280K | – | 2297 |
|
|
2021
Q1 | $280K | Sell |
6,700
-9,400
| -58% | -$393K | ﹤0.01% | 2101 |
|
|
2020
Q4 | $750K | Buy |
+16,100
| New | +$750K | ﹤0.01% | 1901 |
|
|
2020
Q3 | – | Sell |
-13,813
| Closed | -$663K | – | 2568 |
|
|
2020
Q2 | $663K | Buy |
13,813
+100
| +0.7% | +$4.8K | ﹤0.01% | 1903 |
|
|
2020
Q1 | $631K | Sell |
13,713
-13,414
| -49% | -$617K | ﹤0.01% | 1462 |
|
|
2019
Q4 | $1.63M | Buy |
+27,127
| New | +$1.63M | ﹤0.01% | 1198 |
|
|
2018
Q3 | – | Sell |
-4,030
| Closed | -$305K | – | 1296 |
|
|
2018
Q2 | $305K | Sell |
4,030
-4,318
| -52% | -$327K | ﹤0.01% | 969 |
|
|
2018
Q1 | $440K | Sell |
8,348
-167,838
| -95% | -$8.85M | ﹤0.01% | 969 |
|
|
2017
Q4 | $9.41M | Sell |
176,186
-39,809
| -18% | -$2.13M | 0.02% | 459 |
|
|
2017
Q3 | $12.9M | Buy |
215,995
+212,495
| +6,071% | +$12.7M | 0.03% | 340 |
|
|
2017
Q2 | $276K | Buy |
+3,500
| New | +$276K | ﹤0.01% | 959 |
|